4-AMINO-N-(1,3-DIMETHYLPYRAZOL-4-YL)-3-METHYL-N-((6-(TRIFLUOROMETHYL)IMIDAZO(1,2-A)PYRIDIN-2-YL)METHYL)-1,3-DIHYDROFURO(3,4-C)QUINOLINE-8-CARBOXAMIDE, (3R)-
UNII D6C7PM4PJP
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-amino-n-(1,3-dimethylpyrazol-4-yl)-3-methyl-n-((6-(trifluoromethyl)imidazo(1,2-a)pyridin-2-yl)methyl)-1,3-dihydrofuro(3,4-c)quinoline-8-carboxamide, (3r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D6C7PM4PJP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3025067-18-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H24F3N7O2 FSXUKSJPOCOBOY-OAHLLOKOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-amino-n-(1,3-dimethylpyrazol-4-yl)-3-methyl-n-((6-(trifluoromethyl)imidazo(1,2-a)pyridin-2-yl)methyl)-1,3-dihydrofuro(3,4-c)quinoline-8-carboxamide, (3r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.